Elizabeth Long

Chief Financial Officer at Rubicon Genomics, Inc.

Elizabeth Long

Elizabeth Long

Chief Financial Officer at Rubicon Genomics, Inc.

Overview
Career Highlights

Rubicon Genomics, Inc.
ARCH Development Partners LLC
NephRx Corp.

RelSci Relationships

522

Number of Awards

1

Relationships
RelSci Relationships are individuals Elizabeth Long likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman & Chief Executive Officer at Rubicon Genomics, Inc.

Relationship likelihood: Strong

Managing Partner at ARCH Development Partners LLC

Relationship likelihood: Strong

Co-Founder at Rubicon Genomics, Inc.

Relationship likelihood: Strong

President & Chief Operating Officer at Rubicon Genomics, Inc.

Relationship likelihood: Strong

Venture Advisor at ARCH Development Partners LLC

Relationship likelihood: Strong

Advisor at ARCH Development Partners LLC

Relationship likelihood: Strong

President & Chief Executive Officer at FB Corp. (Missouri)

Relationship likelihood: Strong

Senior Director Commercial Operations at Rubicon Genomics, Inc.

Relationship likelihood: Strong

Strategic Advisor at OCA Venture Partners LLC

Relationship likelihood: Strong

Chief Medical Officer at Metabolic Solutions Development Co. LLC

Relationship likelihood: Strong

Paths to Elizabeth Long
Potential Connections via
Relationship Science
You
Elizabeth Long
Chief Financial Officer at Rubicon Genomics, Inc.
Education
MA Degree in Accountancy

Western Michigan University is a national research university enrolling nearly 25,000 students from across the United States and more than 100 other countries. Founded in 1903, it is a learner-centered, discovery-driven and globally engaged public university that stands out among America's more than 5,000 higher education institutions.

Career History
Chief Financial Officer
2009 - Current

Rubicon Genomics, Inc. engages in the provision of pre-analytical amplification technologies. The firm specializes in enzymology, nucleic acid chemistry, sample processing and manufacturing. The company was founded by Dr. John Langmore and Vladimir Makarov in 2000 and is headquartered in Ann Arbor, MI.

Chief Financial Officer
2004 - Current

ARCH Development Partners focuses on making pre-seed and seed stage investments in research-based technology companies. The firm seeks to identify opportunities based on unique intellectual property. They are particularly interested in technology companies operating in the biotechnology/life sciences, wireless, software and technology infrastructure industries. The firm focuses on investments in companies located in the Midwestern region of the US, with a primary emphasis on companies located in Illinois, Ohio, Indiana and Michigan.

Treasurer
Current

NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan.

Transactions
Details Hidden

NephRx Corp. raised money in a private placement transaction

Awards & Honors
CPA (Certified Public Accountant)
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Elizabeth Long. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Elizabeth Long's profile does not indicate a business or promotional relationship of any kind between RelSci and Elizabeth Long.